terazosin

Generic: terazosin

Labeler: a-s medication solutions
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name terazosin
Generic Name terazosin
Labeler a-s medication solutions
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

terazosin hydrochloride 1 mg/1

Manufacturer
A-S Medication Solutions

Identifiers & Regulatory

Product NDC 50090-7851
Product ID 50090-7851_bba25161-4506-4e35-a98a-deff97b5d23f
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA075614
Listing Expiration 2027-12-31
Marketing Start 2021-04-30

Pharmacologic Class

Classes
adrenergic alpha-antagonists [moa] alpha-adrenergic blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 500907851
Hyphenated Format 50090-7851

Supplemental Identifiers

RxCUI
313215
UNII
D32S14F082

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name terazosin (source: ndc)
Generic Name terazosin (source: ndc)
Application Number ANDA075614 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 1 mg/1
source: ndc
Packaging
  • 30 CAPSULE in 1 BOTTLE (50090-7851-0)
  • 90 CAPSULE in 1 BOTTLE (50090-7851-1)
source: ndc

Packages (2)

Ingredients (1)

terazosin hydrochloride (1 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "bba25161-4506-4e35-a98a-deff97b5d23f", "openfda": {"unii": ["D32S14F082"], "rxcui": ["313215"], "spl_set_id": ["916cf0fa-8e39-4b4d-b564-a16aa8511ff6"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE (50090-7851-0)", "package_ndc": "50090-7851-0", "marketing_start_date": "20260108"}, {"sample": false, "description": "90 CAPSULE in 1 BOTTLE (50090-7851-1)", "package_ndc": "50090-7851-1", "marketing_start_date": "20260108"}], "brand_name": "terazosin", "product_id": "50090-7851_bba25161-4506-4e35-a98a-deff97b5d23f", "dosage_form": "CAPSULE", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "50090-7851", "generic_name": "terazosin", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "terazosin", "active_ingredients": [{"name": "TERAZOSIN HYDROCHLORIDE", "strength": "1 mg/1"}], "application_number": "ANDA075614", "marketing_category": "ANDA", "marketing_start_date": "20210430", "listing_expiration_date": "20271231"}